Boston, MA -- (SBWIRE) -- 12/01/2016 -- Immunomodulators are the drugs that help to regulate the immune system. These drugs either stimulate the weak immune systems or moderate the overactive immune systems. Though many drugs are available in the market, there still exists a huge unmet need in the autoimmune and inflammatory immunomodulators market as there are no medicines that provide complete cure to some diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease.

Technavio's analysts forecast the global autoimmune and inflammatory immunomodulators market to grow at a CAGR of 7.01% during the period 2016-2020.

Get More Details on this Report and a Full Table of Contents at Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020

Covered in this report

The report covers the present scenario and the growth prospects of the global autoimmune and inflammatory immunomodulators market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-AbbVie
-Johnson & Johnson
-Amgen
-F. Hoffmann-La Roche
-Pfizer

Other prominent vendors

-AstraZeneca
-Avaxia Biologics
-Biogen Idec
-Bristol-Myers Squibb
-Boehringer Ingelheim
-Eli Lilly
-Enlivex Therapeutics
-Gilead Sciences
-Immune Pharmaceuticals
-Merck
-Mitsubishi Tanabe Pharma
-Neovacs
-Prometheus Laboratories
-Sandoz
-Sanofi
-Swedish Orphan Biovitrum
-Takeda Pharmaceuticals
-UCB

Market driver

-Development of novel therapies using innovative technologies.
-For a full, detailed list, view our report

Market challenge

-Discontinuation of drugs under development leading to substantial loss in revenue.
-For a full, detailed list, view our report

Market trend

-Advent of biosimilars expected to improve the treatment rates.
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: AbbVie, Johnson & Johnson, Amgen, F. Hoffmann-La Roche, Pfizer, AstraZeneca, Avaxia Biologics, Biogen Idec, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, Enlivex Therapeutics, Gilead Sciences, Immune Pharmaceuticals, Merck, Mitsubishi Tanabe Pharma, Neovacs, Prometheus Laboratories, Sandoz, Sanofi, Swedish Orphan Biovitrum, Takeda Pharmaceuticals, UCB

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:
-Global Autoimmune Drugs Market 2016-2020
-Acquired (Autoimmune) Hemolytic Anemia Global Clinical Trials Review, H2, 2015
-Inflammatory Skin Diseases Global Clinical Trials Review, H2, 2015
-Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015
-Inflammatory Pain Global Clinical Trials Review, H1, 2016